62 related articles for article (PubMed ID: 38559424)
1. Pan-cancer analysis of the disulfidptosis-related gene
Zong Y; Zhu A; Liu P; Fu P; Li Y; Chen S; Gao X
Heliyon; 2024 Jun; 10(11):e31875. PubMed ID: 38845861
[TBL] [Abstract][Full Text] [Related]
2. Association analysis of FXYD5 with prognosis and immunological characteristics across pan-cancer.
Bai Y; Li L; Li J; Lu X
Heliyon; 2024 May; 10(9):e30727. PubMed ID: 38774095
[TBL] [Abstract][Full Text] [Related]
3. Pan-Cancer Analysis and Experimental Validation of CEND1 as a Prognostic and Immune Infiltration-Associated Biomarker for Gliomas.
Ma J; Lang B; Wang L; Zhou Y; Fu C; Tian C; Xue L
Mol Biotechnol; 2024 Jun; ():. PubMed ID: 38836983
[TBL] [Abstract][Full Text] [Related]
4. Insights into the prognostic value and immunological role of CD74 in pan-cancer.
Liu Z; Chen M; Zheng W; Yuan S; Zhao W
Discov Oncol; 2024 Jun; 15(1):222. PubMed ID: 38861249
[TBL] [Abstract][Full Text] [Related]
5. CSE1L as a prognostic biomarker associated with pan cancer immune infiltration and drug sensitivity.
Li H; Wang L; Ruan Z; Li X; Yang Y; Fang J; Wang R
Expert Rev Clin Immunol; 2024 May; ():1-13. PubMed ID: 38752776
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive pan-cancer analysis reveals the versatile role of GALNT7 in epigenetic alterations and immune modulation in cancer.
Liu Y; Sun Y; Xiao M; Li S; Shi S
Heliyon; 2024 Jun; 10(11):e31515. PubMed ID: 38845941
[TBL] [Abstract][Full Text] [Related]
7. ACTL6A: unraveling its prognostic impact and paving the way for targeted therapeutics in carcinogenesis.
Eid RA; Mamdouh F; Abdulsahib WK; Alshaya DS; Al-Salmi FA; Ali Alghamdi M; Jafri I; Fayad E; Alsharif G; Zaki MSA; Alshehri MA; Noreldin AE; Alaa Eldeen M
Front Mol Biosci; 2024; 11():1387919. PubMed ID: 38872915
[No Abstract] [Full Text] [Related]
8. Pan-cancer analysis of the prognostic and immunological role of GJB2: a potential target for survival and immunotherapy.
Jia Y; Guo B; Zhang W; Wang F; Zhang Y; Zhang Q; Li E
Front Oncol; 2023; 13():1110207. PubMed ID: 37427102
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Immunological Significance of ANKRD52 in Pan-Cancer.
Yin HZ; Zhang MC; Wu H
Biochem Genet; 2024 Jan; ():. PubMed ID: 38296907
[TBL] [Abstract][Full Text] [Related]
10. Multi-omics analysis of TLCD1 as a promising biomarker in pan-cancer.
Wang S; Zhang M; Sun H; Li T; Hao J; Fang M; Dong J; Xu H
Front Cell Dev Biol; 2023; 11():1305906. PubMed ID: 38559424
[No Abstract] [Full Text] [Related]
11. Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer.
Chen P; Xu J; Cui Z; Wu S; Xie T; Zhang X
Front Immunol; 2023; 14():1071675. PubMed ID: 36761737
[TBL] [Abstract][Full Text] [Related]
12. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
[No Abstract] [Full Text] [Related]
13. A pan-cancer analysis to determine the prognostic analysis and immune infiltration of HSPA5.
Zhu RK; Zhang W; Zhang YX; Hui Z; Wang XW
Curr Cancer Drug Targets; 2023 May; ():. PubMed ID: 37157205
[TBL] [Abstract][Full Text] [Related]
14. Pan-cancer evidence of prognosis, immune infiltration, and immunotherapy efficacy for annexin family using multi-omics data.
Shen C; Zhang S; Zhang Z; Yang S; Zhang Y; Lin Y; Fu C; Li Z; Wu Z; Wang Z; Li Z; Guo J; Li P; Hu H
Funct Integr Genomics; 2023 Jun; 23(3):211. PubMed ID: 37358720
[TBL] [Abstract][Full Text] [Related]
15. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
